Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Botulinum Toxin Type A Treatment Report
What is Botulinum Toxin Type A?

Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.

Side Effects

Side effects as an overall problem

Severe
1 9%
Moderate
2 18%
Mild
1 9%
None
7 64%

Most commonly reported side effects

Pain during Injection
1 9%
too strong, muscle weakness,can't hold head or shoulder upright without support
1 9%
mild burning along muscle injected
1 9%
Muscle spasms less often, can function almost normal
1 9%
Numbness
1 9%
no quality control of strengh of botox, weak batch or too strong
1 9%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Botulinum Toxin Type A. See all 19 dosages

  100units as needed 175IU as needed 200 intl units as needed 200IU as needed 2 100units as needed 300mg as needed 3 100units as needed as needed IU as needed 3 mg yearly 100 units yearly 100 units monthly 200 intl units monthly 200 units monthly 100 units daily 100 units one time 200 app one time 200 intl units one time 300 units one time
  5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Botulinum Toxin Type A (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
6 55% Did not seem to work: 55%
Course of treatment ended
6 55% Course of treatment ended: 55%
Expense
4 36% Expense: 36%
Other
4 36% Other: 36%
Side effects too severe
1 9% Side effects too severe: 9%

See all 11 patients who’ve stopped taking Botulinum Toxin Type A

Currently Taking Botulinum Toxin Type A

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
3
1
4
6
3

Stopped Taking Botulinum Toxin Type A

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
3
1
2
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
9 82%
Usually
1 9%
Sometimes
1 9%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 9%
Somewhat
4 36%
A little
1 9%
Not at all
5 45%

Cost

Paid out of pocket

$200+
2 18%
$100-199
2 18%
$50-99
1 9%
$25-49
0 0%
< $25
1 9%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.